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Abstract
Background The skeletal muscle system plays an important role in the independence of older adults. In this study we examine differ-
ences in the skeletal muscle transcriptome between healthy young and older subjects and (pre-)frail older adults. Additionally, we exam-
ine the effect of resistance-type exercise training on the muscle transcriptome in healthy older subjects and (pre-)frail older adults.
Methods Baseline transcriptome proﬁles were measured in muscle biopsies collected from 53 young, 73 healthy older sub-
jects, and 61 frail older subjects. Follow-up samples from these frail older subjects (31 samples) and healthy older subjects
(41 samples) were collected after 6 months of progressive resistance-type exercise training. Frail older subjects trained twice
per week and the healthy older subjects trained three times per week.
Results At baseline genes related to mitochondrial function and energy metabolism were differentially expressed between
older and young subjects, as well as between healthy and frail older subjects. Three hundred seven genes were differentially
expressed after training in both groups. Training affected expression levels of genes related to extracellular matrix, glucose
metabolism ,and vascularization. Expression of genes that were modulated by exercise training was indicative of muscle strength
at baseline. Genes that strongly correlated with strength belonged to the protocadherin gamma gene cluster (r=0.73).
Conclusion Our data suggest signiﬁcant remaining plasticity of ageing skeletal muscle to adapt to resistance-type exercise train-
ing. Some age-related changes in skeletal muscle gene expression appear to be partially reversed by prolonged resistance-type ex-
ercise training. The protocadherin gamma gene cluster may be related to muscle denervation and re-innervation in ageing muscle.
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Introduction
The number of people aged 65 and above has increased rap-
idly over the past few decades and is likely to increase pro-
gressively.1 Because senescence is associated with a wide
range of afﬂictions, including physical disability, cancer, heart
disease, and diabetes, the demand for care for older people
will further increase. The loss of skeletal muscle mass and
function with ageing leads to frailty and results in the loss of
independence of older adults.
Frailty and related sarcopenia are very complex, and many
factors contribute to their aetiology. This includes physical in-
activity, malnutrition, hormonal changes, and changes within
the muscle.2–4 Mitochondrial function decreases with age,5
fast-twitch muscle ﬁbres demonstrate a smaller cross-sectional
area,6 protein synthesis capacity is reduced,7 anabolic signals are
less effective,4,8 and there are fewer satellite cells to regulate adap-
tive responses to stimuli.9 In older adults muscle cells can also un-
dergo continuous cycles of denervation and reinnervation, which
can lead to both weakness and loss of muscle mass.10,11
OR IG INAL ART ICLE
© 2016 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society of Sarcopenia, Cachexia and Wasting Disorders
Journal of Cachexia, Sarcopenia and Muscle (2016)
Published online in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/jcsm.12099
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium,
provided the original work is properly cited, the use is non-commercial and no modiﬁcations or adaptations are made.
One of the most effective strategies to improve muscle mass
and strength in adults is physical exercise.9,12 Resistance-type
exercise is particularly suitable to curtail muscle loss and mus-
cle weakness in older people. In accordance, quality of life is
improved after participating in resistance-type exercise train-
ing.13 Some even claim that resistance-type exercise training
reverses ageing in skeletal muscle.14
To elucidate some of these complex processes that occur in
skeletal muscle during ageing, we examined the effects of
prolonged resistance-type exercise training in frail and healthy
older subjects on the skeletal muscle transcriptome. By comparing
genome-level gene expression in frail and pre-frail older subjects,
healthy older subjects, and young subjects we aim to better under-
stand themolecular causes of frailty. Secondly, we aimed to deter-
mine the effect of resistance-type exercise training on the skeletal
muscle transcriptome in both frail and healthy older people.
Methods
Experimental design
We collected a total of 259 muscle biopsy samples from pre-
frail and frail older subjects (61 subjects, 92 samples), healthy
older subjects (73 subjects, 114 samples), and young males
(53 subjects, 53 samples). Some of these samples were
follow-up samples taken after 24 weeks of resistance-type ex-
ercise training (31 samples from the frail older subjects, 41
samples from the healthy older subjects). Training for both
groups was similar and consisted of progressive full-body
resistance-type exercise training. However, the frail older
group had training sessions twice per week, whereas the
healthy older group trained three times per week. In addition,
subjects took a protein or control drink for the duration of the
study. The healthy older group received a 15g portion of milk
protein or control supplement at breakfast. The frail older group
received a similar drink containing 15g supplement drink (milk
protein or control) at breakfast and lunch. More details can be
found in the respective papers.15,16 Table 1 shows the character-
istics of our study population at baseline.Table 2 shows the effect
of the training intervention on the older subjects that were in-
cluded in this study and where follow-up data are available.
Subjects
Biopsies from frail and pre-frail older subjects were collected
from participants of two studies performed by Tieland
et al.15,17 For these studies frail and pre-frail older subjects were
selected based on the Fried criteria for frailty.2 These subjects
will hereafter be referred to as frail older subjects. These charac-
teristics are unintentional weight loss, weakness, self-reported
exhaustion, slow walking speed, and low physical activity. Sub-
jects in the healthy older group were not considered frail by
any of these criteria at the start of the intervention study.16 Sev-
eral additional baseline samples from healthy older subjects
were collected from several studies from our group.18,19 These
samples were taken before any intervention was undertaken
and serve as additional reference samples. Baseline samples
from young subjects were from healthy male subjects.20 These
were also taken before any intervention took place and serve
as reference samples. All studies were approved by the medical
ethical committee of eitherWageningen University orMaastricht
University and comply with the Declaration of Helsinki.
Muscle biopsy
Muscle samples were obtained with a 5mm Bergstrom mus-
cle biopsy needle from the Musculus vastus lateralis, after lo-
cal anaesthesia of the skin and fascia. Samples were freed
from any visible blood and non-muscle tissue and immedi-
ately frozen in liquid nitrogen and then stored at 80°C. All
samples were obtained in the morning, in an overnight fasted
state, after at least 3 days of no heavy physical activity.
Sample preparation and microarray analysis
Total RNA was isolated from the skeletal muscle tissue by using
Trizol reagent (Invitrogen, Breda, Netherlands). Thereafter, RNA
was puriﬁed using the Qiagen RNeasy Micro kit (Qiagen, Venlo,
Netherlands), and RNA quality was checked using an Agilent
2100 bioanalyzer (Agilent Technologies, Amsterdam, Netherlands).
Total RNA (100ng) was labelled using an Ambion WT expression
kit (Life Technologies, Bleiswijk, Netherlands) and hybridized to
Table 1 Subject characteristics of the baseline only subjects
FE HE YO
N (male / female) 24 / 6 27 / 5 53 / 0
Age (years) 79.8±8.9 74.1±4.5 21.3± 2.4
Height (m) 1.71±0.09 1.73±0.08 1.84± 0.06
Weight (kg) 80± 12.4 75.9±12.9 76.5± 10.3
BMI (kg/m2) 27.3±4.2 25.2±3.2 22.6± 3
Body Fat (%) 28.8±7.2 23.4±5.5 15.4± 4.6
Lean Mass (kg) 52.1±6.3 55.5±8.6 61.9± 6
Leg Extension 1RM (kg) 65± 20 68±17 124±20
Leg Press 1RM (kg) 127± 31 155±41 203±36
Mean ± SD. FE= frail older subjects, HE=healthy older subjects, YO= young male subjects.
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human whole genome Genechip Human Gene 1.1 ST arrays
coding 19.732 genes, (Affymetrix, Santa Clara, CA). Sample
labelling, hybridization to chips, and image scanning were
performed according manufacturer’s instructions.
Data analysis
Microarray signals were normalized using robust multichip aver-
age. Data were ﬁltered using Universal exPression Codes ﬁltering
with a 50% cut-off, corresponding to a 50% likelihood that a
gene is expressed.21 Signiﬁcant differences of individual genes
were tested using the limma R library.22 Baseline differences
were tested between the three groups (frail older, healthy older,
or young). Our model included gender, supplementation, and
group. For the effect of exercise we included subject, gender,
time, and supplementation in the model. The training effect
for frail older and healthy older subjects was analysed separately
because of differences in training frequency. P-values were ad-
justed using false discovery rate.23 A q-value below 0.05 was
considered signiﬁcant. Pathway analyses were performed using
Ingenuity Pathway Analysis (IPA, QIAGEN Redwood City, www.
qiagen.com/ingenuity) on the ﬁltered dataset with the Universal
exPression Codes ﬁltering ﬁltered genes used as the background.
A sparse partial least squares (sPLS) model for leg extension 1RM
(Figure 1) was made using the caret R library.24 The dataset was
split into a training set (75%) and a testing set (25%) before
ﬁtting the model using cross validation. This model was vali-
dated using 10 times repeated tenfold cross validation. Final
number of components for the sPLS model selected by grid
search was 3. Principal component analysis was performed
using the FactoMineR R library.25 Plots were made using the
R libraries ggplot2 and gplots.26,27
Results
Baseline differences in transcriptome
Large differences in gene expression proﬁles between
young and older adults (healthy and frail) were found, with
the expression of 5228 genes signiﬁcantly different between
young subjects and both groups of older subjects. However,
fold changes of the majority of these genes were relatively
subtle, which suggested small but consistent differences be-
tween these groups. Only 825 genes out of these 5228
genes showed fold changes higher than 1.2. Venn-diagrams
can be found in the Supporting Information, Figures S1A
and S1B. The top 20 genes that were signiﬁcantly different
at baseline between the three groups are presented in Ta-
ble 3. Top canonical pathways reported by IPA include oxi-
dative phosphorylation, TCA cycle and glucose metabolism
(Supporting Information, Figure S2) (Figure 2).
Table 4 shows the top 20 genes that were different be-
tween healthy and frail older subjects at baseline. Top genes
included METTL21C, FRZB, and non-coding RNAs. Pathways
that were signiﬁcantly different between the frail and
healthy older subjects were related to glucose metabolism
and RNA processing (Supporting Information, Figure S2). In
general, expression of genes related to glucose metabolism
were lower in both frail older and healthy older subjects
compared with young, with frail older subjects showing the
lowest expression of the groups. Principal component analy-
sis summarizes this observation, where the healthy older
subjects seemed to be between the frail older subjects and
the young subjects on the ﬁrst two components (Supporting
Information, Figures S3 and S4). While pathways related to
mitochondrial function were some of the most signiﬁcantly
affected pathways, the fold changes of the individual mito-
chondrial genes were relatively small but consistent. Fold
changes for these mitochondrial genes were in the range
of 1.1 and 1.2.
Effect of prolonged resistance-type exercise
training
Prolonged resistance-type exercise training showed a signif-
icant effect on the gene expression proﬁles in both frail and
healthy older people (431 and 1395 signiﬁcantly changed
genes, respectively). Three hundred seven genes were
Table 2 Subject characteristics of the subjects with before and after samples
FE before training FE after training HE before training HE after training
N (male/female) 11 / 20 26 / 15
Age (years) 76.5± 7.0 69.9± 5.0
Height (m) 1.66± 0.09 1.71± 0.09
Weight (kg) 78.5± 13.6 79.6± 14.1* 76.7± 13.2 77.1±13.2
BMI (kg/m2) 28.5± 4.1 29±4.3 * 26.1± 2.8 26.2±2.8
Body Fat (%) 36.7± 8.5 36.6± 8.8 25.9± 5.9 24.4±5.9 *
Lean Mass (kg) 46.1± 10.0 46.9± 9.9 * 54.6± 11.1 56.0±11.3 *
Leg Extension 1RM (kg) 59±18 81±24 * 81±17 114±23 *
Leg Press 1RM (kg) 130±35 178±49 * 179±40 230±50 *
Mean ± SD. FE= frail older subjects, HE=healthy older subjects, YO= young male subjects.
*A signiﬁcant effect of resistance-type exercise training (P< 0.05).
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changed in both groups after resistance-type exercise train-
ing. Changes in expression of all these overlapping genes
were in the same direction. A table with the top 20 genes
changed by training is presented in Table 5. Training re-
sulted in the differential expression levels of many genes
that are related to the connective tissue and the extracel-
lular matrix, including collagen genes and laminin genes,
suggesting signiﬁcant tissue remodelling because of the
training. Upstream analysis using IPA showed that TGF-β
signalling-related genes were signiﬁcantly activated in both
groups, primarily because of the increased expression of
collagen and laminin genes (Supporting Information,
Figure S5). Other signiﬁcant genes include myoﬁbrillar pro-
teins such as myosin heavy chain isoforms and troponin
isoforms.
Genes related to glucose metabolism shifted away from the
expression levels of the older subjects at baseline towards the
levels of the younger phenotype. This trend is reﬂected in
many other genes, where the majority of genes signiﬁcantly
changed by exercise training shifted towards ‘younger’
Figure 1 A and B—Change of leg extension 1RM after prolonged exercise training for each individual. Left are frail older subjects, right are healthy
older subjects.
Table 3 Top 20 genes signiﬁcantly different between young and older subjects
Gene FC FE vs. HE FC FE vs. YO FC HE vs. YO q-value FE vs. HE q-value FE vs. YO q-value HE vs. YO
IGFN1 1.12 6.43 5.71 0.64 0.00 0.00
UNC13C 1.07 6.20 5.78 0.60 0.00 0.00
MYLK4 1.35 5.13 3.81 0.07 0.00 0.00
C12orf75 1.45 4.54 3.13 0.01 0.00 0.00
SLC38A1 1.11 3.50 3.14 0.55 0.00 0.00
HCN1 1.16 3.36 2.90 0.30 0.00 0.00
MYH8 1.16 3.28 2.83 0.50 0.00 0.00
CFAP61 1.36 3.39 2.49 0.00 0.00 0.00
NR4A3 1.86 3.70 2.00 0.02 0.00 0.00
FAM83B 1.11 2.91 2.63 0.39 0.00 0.00
DAAM2 1.06 2.51 2.36 0.42 0.00 0.00
NNMT 1.33 2.71 2.04 0.03 0.00 0.00
ZNF382 1.21 2.09 2.54 0.05 0.00 0.00
TPPP3 1.33 2.62 1.97 0.01 0.00 0.00
COL28A1 1.07 2.36 2.20 0.42 0.00 0.00
METTL21EP 1.05 2.19 2.29 0.78 0.00 0.00
HIST1H3E 1.11 2.08 2.30 0.30 0.00 0.00
SNORD115-32 1.02 2.17 2.14 0.91 0.00 0.00
SERPINA5 1.04 2.11 2.19 0.89 0.00 0.00
METTL21C 1.98 2.84 1.44 0.00 0.00 0.03
FE= frail older subjects, HE=healthy older subjects, YO= young men.
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expression levels (325 genes out of 431 in the frail older sub-
jects, 1106 out of 1395 in the healthy older subjects). Figure 3
shows a heat map of 184 genes that were signiﬁcantly
changed by training in both groups and were signiﬁcant when
comparing young with either frail or healthy older subjects.
Most of these genes shifted towards younger levels.
To further analyse the relationship between the 307 genes
that were robustly changed after training in both groups (q-
value< 0.05) we performed sPLS regression to calculate leg
extension 1RM based on gene expression in the baseline
samples. The aim was to evaluate whether differences in ex-
pression of the genes that were changed by training repre-
sent the overall strength of the muscle at baseline. The
samples obtained after training were excluded for this anal-
ysis. A plot of the predicted leg extension 1RM strength
against the measured leg extension 1RM strength is pre-
sented in Figure 4. Gene importance for the ﬁnal model is
presented in Table 6. Cross-validation mean R2 of the model
was 0.73; the mean RMSE was 17.7. The RMSE for the
withheld testing set was 19.1. The top genes contributing
to the model include genes from the protocadherin gamma
gene cluster, CTNNBIP1, CFAP61 (C20orf26), C12orf75, and
USP54. We calculated the eigengene for all protocadherin
gamma genes and correlated this eigengene with leg
extension 1RM. The protocadherin gamma eigengene
showed a strong direct negative correlation (Pearson
r =0.73) with 1RM leg extension strength. A plot of this
negative correlation is presented in the Supporting Infor-
mation, Figure S7.
Discussion
In this study we compared the transcriptomes of skeletal
muscle of healthy young, healthy older, and frail older sub-
jects to better understand the skeletal muscle related part
of the frail phenotype. A schematic overview of our ﬁndings
is presented in Figure 5. To our knowledge this is the ﬁrst
Figure 2 A and B—Change of lean body mass after prolonged exercise training for each individual. Left are frail older subjects, right are healthy older
subjects.
Table 4 Top 20 genes signiﬁcantly different between the frail and
healthy older adults at baseline
Gene FC FE vs. HE q-value FE vs. HE
METTL21C 1.98 0.00
NR4A3 1.86 0.02
VTRNA1-1 1.71 0.00
MIR206 1.58 0.00
SNORA38B 1.58 0.00
S100A8 1.51 0.04
FRZB 1.48 0.03
HES1 1.47 0.00
P2RY13 1.46 0.00
MIR133B 1.45 0.01
C12orf75 1.45 0.01
SNORA60 1.44 0.00
SNORD60 1.43 0.00
LYZ 1.43 0.03
SNORD80 1.42 0.00
SNORD82 1.42 0.00
SNORD29 1.41 0.00
EVI2B 1.40 0.01
UPK3A 1.40 0.00
ID1 1.40 0.00
FE= frail older subjects, HE=healthy older subjects.
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Table 5 Top 20 genes signiﬁcantly different in both frail and healthy older subjects after training. FE = frail older subjects, HE = healthy older subjects
Gene FC FE training FC HE training q-value FE training q-value HE training
FRZB 1.97 1.55 0.00 0.00
IGFN1 1.58 1.80 0.04 0.00
MYLK4 1.45 1.69 0.01 0.00
COL3A1 1.45 1.68 0.01 0.00
ANKRD2 1.44 1.61 0.01 0.00
THBS4 1.34 1.66 0.05 0.00
PFKFB3 1.61 1.38 0.01 0.01
COL4A1 1.35 1.46 0.00 0.00
CAPN6 1.37 1.45 0.03 0.00
COL1A2 1.35 1.45 0.03 0.00
EDNRB 1.24 1.56 0.01 0.00
GCNT2 1.51 1.28 0.00 0.00
CFAP61 1.24 1.54 0.03 0.00
C12orf75 1.42 1.33 0.01 0.00
CCDC80 1.34 1.40 0.03 0.00
OLFML2B 1.38 1.34 0.00 0.00
SPARC 1.28 1.44 0.00 0.00
COL4A2 1.32 1.37 0.00 0.00
LGI1 1.31 1.33 0.02 0.00
ACOT11 1.30 1.34 0.04 0.00
Figure 3 Heatmap of 184 genes that are signiﬁcantly different between young and older subjects and are signiﬁcantly changed by prolonged resis-
tance-type exercise training in both groups.
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study investigating the effect of age on the muscle tran-
scriptome to include frail and pre-frail older subjects. We ob-
served clear and pronounced differences at baseline between
young and older subjects. In our data frailty seems to present
itself in the muscle transcriptome primarily as a more ad-
vanced stage of ageing (refer also to the Supporting Informa-
tion, Figures S3 and S4). This may, at least partly, be because
of the higher average age of the frail group. There is, how-
ever, still signiﬁcant overlap in age because of the high varia-
tion in age in both groups (79.8 ± 8.9, 74.1 ± 4.5 mean age and
standard deviation for frail and healthy older subjects,
respectively; Tables 1 and 2).
Baseline differences between young and older
subjects
There were signiﬁcant differences in genes related to mito-
chondrial function and oxidative phosphorylation (Supporting
Information, Figure S2). It is well known that mitochondrial
function is impaired in older adults,5 which can be a respon-
sive feature to muscle inactivity28 and mitochondrial protein
carbonylation.29 In this case the average expression of mito-
chondrial genes is lowest in the frail older subjects at base-
line. These expression differences may also represent a
lower abundance of mitochondria.6
There are two genes among the top differentially
expressed genes between the three baseline groups that
are as yet unknown, CFAP61 (C20orf26) and C12orf75. Both
genes have higher expression levels in the older subjects,
and training appears to attenuate expression of these genes.
Not much is known about the function of CFAP61 except that
it is highly expressed in skeletal muscle tissue and may be re-
lated to calcium signalling and/or energy conversion.30
C12orf75 may be related to cell proliferation and stem cell
signalling.31
In our data frail subjects showed signiﬁcantly higher expres-
sion levels of METTL21C compared to both the young and
healthy older subjects, with a greater fold change difference
between healthy and frail subjects than between the young
and the older subjects (Table 3). Training decreases the mean
expression of METTL21C in both groups, but this does not
reach signiﬁcance using our signiﬁcance cut-off. However, in
the frail group it does reach a q-value of 0.08 after training,
showing a fold change of 1.58. METTL21C encodes for a
protein–lysine methyltransferase belonging to a group of pro-
teins that are involved in methylation of chaperone proteins,
where METTL21C appears to methylate HSP70 and HSP9032
and has recently been found to be associated with skeletal
muscle development.33 In vitro inhibition of METTL21C expres-
sion in myoblasts showed impaired myotube differentiation
and calcium signalling, suggesting that METTL21C plays an im-
portant role in the function of muscle cells and possibly also
overall quality of the muscle.
Effect of prolonged resistance-type exercise
training
The majority of genes that signiﬁcantly changed following
prolonged resistance-type exercise training showed a shift
in the expression levels towards levels observed in the youn-
ger group (Figure 3). A previous study has shown a similar ef-
fect.14 Indeed, Melov et al. state that training reverses the
effect of ageing. While there is a shift towards younger ex-
pression levels, this does not necessarily mean that there is
reversal of ageing. A more likely explanation is that the skel-
etal muscle in these older subjects have been ‘detrained’
Figure 4 Scatter plot of predicted leg extension 1RM of the baseline
samples using sPLS and the actual measured 1RM. Red dots indicate sam-
ples that were part of the testing data set (25% of the total data set).
Table 6 Variable importance and coefﬁcients of the top 20 variables for
the sPLS model
Gene Variable importance Coefﬁcient
CFAP61 100 1.94
PCDHGA10 99.3 0.82
PCDHGB5 97.6 1.18
PCDHGB1 95.1 1.02
CTNNBIP1 91.9 1.12
USP54 90.6 0.86
PCDHGA8 83.5 0.91
PCDHGB7 82.4 0.80
MYOZ2 81.3 0.61
PCDHGA11 78.5 0.64
C12orf75 78.2 0.82
PCDHGA7 77.8 0.86
PCDHGA2 76.4 0.91
HEXIM2 75.9 0.24
GRSF1 75.2 0.39
GCNT2 75.1 1.06
FBP2 72.3 0.26
PLEKHO1 68.5 0.24
CRY2 68.1 1.60
PABPC4 67.5 0.85
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because of more sedentary lifestyle when compared with
healthy younger controls. Physical inactivity is a major con-
tributor to age-related muscle loss and weakness and is one
of the criteria of frailty.2 In this way participation in prolonged
resistance-type exercise training is likely to shift gene expres-
sion to younger levels. Furthermore, in our data the young
subjects had higher muscle strength (Table 1). Training leads
to subtle but consistent changes in the muscle tran-
scriptome.34 Thus, a shift towards younger expression levels
would be consistent with the increased strength after
prolonged resistance-type exercise training.
The genes that shift towards younger expression levels
include genes related to the extracellular matrix, vasculariza-
tion, glucose metabolism, and muscle contraction (Supporting
Information, Figures S2, S5 and S6). The muscle biopsies were
taken at least 3 days after the last training session. Thus, we are
not observing acute effects of a single bout of resistance-type
exercise, but rather longer term consistent changes in gene ex-
pression. Notably absent among the changes induced by
prolonged resistance-type exercise training, however, are the
primary differences observed when we compare young and
older subjects: mitochondrial function. Possible explanations
are that these changes are too subtle to pick up after 24weeks
of resistance-type exercise training or that prolonged resistance-
type exercise training does not signiﬁcantly affect these genes.
Timing of the muscle biopsies relative to the last training session
may also be a factor. It may be that expression of these mito-
chondrial genes only changes acutely after resistance-type exer-
cise rather than chronically.
Prolonged resistance-type exercise training showed fewer
signiﬁcantly affected genes in the frail group. Part of this
can be explained by the differences in treatment. The healthy
older subjects had training sessions three times per week
whereas the frail older subjects received two sessions per
week. The load of the training was also lower for the frail sub-
jects. However, it may also be that the frail older adults are
less capable of adapting to the additional stress of prolonged
resistance-type exercise training. Fortunately, the frail sub-
jects still showed a signiﬁcant response to the training stimu-
lus despite their less adaptive phenotype.2 Others have
already reported that older adults in general have a decreased
response to resistance-type exercise on a transcriptome
level,35 and this may also play a role in the smaller response
in the frail older subjects compared with the healthy older
subjects.
Gene expression and muscle strength
Prolonged resistance-type exercise training led to strength in-
creases in all individuals to the point that training increased
strength levels in the frail older subjects close to the levels ob-
served in the healthy older subjects at baseline (Figure 1).
However, it did not necessarily lead to increases in lean body
mass in all individuals (Figure 2). This suggests that we pri-
marily observed an increase in muscle quality, cross-bridge
cycling efﬁciency, calcium handling and/or neuromuscular ad-
aptation rather than an increase in muscle cross-sectional
area. Our data provide evidence suggesting disturbances in
axon guidance and muscle innervation in the older subjects.
We performed sPLS regression analysis to calculate leg
strength based on expression levels of the genes that are ro-
bustly changed after prolonged exercise training in both groups
in the baseline samples. Our rationale was that because these
genes are changed in both groups after training, where the leg
extension 1RM is signiﬁcantly higher, that expression of these
Figure 5 Scheme summarizing the major ﬁndings of this study.
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genes could also reﬂect muscle strength at baseline without
training.We were able to build a reasonably accurate regression
model to calculate leg extension 1RM at baseline based on gene
expression (mean cross-validation R2 of 0.73 and RMSE of 17.7;
Figure 4). Thus, expression of the genes robustly changed by
exercise also seems to be indicative of muscle strength, not only
after training but also prior to prolonged exercise training. This
suggests that expression of these genes may be used as a
biomarker to training status prior to study entry.
Several of the most important variables in our sPLS model
for muscle strength belonged to the protocadherin gene clus-
ter. Genes of the protocadherin gamma gene cluster were sig-
niﬁcantly different between frail older subjects, healthy older
subjects and young subjects at baseline. Expression of these
genes also went down after training in both groups. Older
subjects had higher expression of this gene than young sub-
jects, and expression was highest in the frail older subjects.
There are good indications that this gene cluster is relevant
for neuromuscular performance. Many of the genes from this
cluster are also signiﬁcantly changed after training in both
groups. Protocadherin gamma genes ranked very highly in
the variable importance for our correlative model for leg ex-
tension 1RM (Table 6).
Protocadherin gamma genes are primarily expressed in neu-
ral tissues such as the brain and the spinal cord and appears to
be involved in axonal guidance.36 Protocadherin proteins show
homeophilic binding to other protocadherin proteins, and in
this way these proteins provide recognition sites for axonal
binding. By expressing different protocadherin gamma genes
from the gene cluster axons can be guided to different loca-
tions.37 In knockout mice these genes appear to be indirectly
related to muscle function: knock-out mice show severe mus-
cle weakness and tremors, although this is attributed to loss
of spinal motor neurons.38,39 It may also be that it is expressed
at the muscle side of the synapse to facilitate axon guidance
towards muscle, and increased expression in this case is be-
cause of the denervation-reinnervation cycles seen in ageing
muscle. Therefore, we hypothesize that as muscle loses inner-
vation it increases expression of the protocadherin gamma
cluster to facilitate axon binding from other nerves.
Protocadherin gamma is not the only signiﬁcant group of
genes related to neuromuscular function that we found in
our data. There are several other genes differentially
expressed between frail and healthy older subjects that are re-
lated to the innervation of muscle, including acetylcholine es-
terase and kyphoscoliosis peptidase (KY). Both play important
roles in the function of the neuromuscular junction.40,41 The
top differentially expressed gene at baseline, unc-13 homolog
C (UNC13C), is involved in neurotransmitter release.42,43 Both
MYLK4 and IGFN1 are also among the top signiﬁcantly differ-
ent genes between the three groups at baseline. Little is
known about MYLK4 and IGFN1, but both have been indirectly
associated with neuromuscular function. MYLK4 has been
shown to be signiﬁcantly downregulated in acetylcholine
esterase knockout mice, together with KY, suggesting that it
is somehow involved in the signal transduction.44 Like KY,
IGFN1 has been associated with both muscle structure and
neurological function.45,46 This gene also binds EEF1A2, which
is the gene associated with the wasted mouse phenotype.46,47
This phenotype shows signiﬁcant immunological and neuro-
muscular defects.48 IGFN1 has many splicing variants, which
suggests that it plays a pleiotropic role in the muscle. Another
indication of denervation is the increased expression of the
perinatal myosin heavy chain isoform MYH8 in older subjects.
Previous studies have found that expression of this gene is in-
creased in tissue where the muscle ﬁbres have lost
innervation.49,51
Conclusions
Our data suggest a signiﬁcant remaining plasticity of ageing
skeletal muscle to adapt to regular resistance-type exercise.
Many age-related changes in skeletal muscle gene expression
are partially reversed by prolonged resistance-type exercise
training. Expression of the genes robustly changed following
prolonged resistance-type exercise training in frail and
healthy older subjects did not only reﬂect the effect of train-
ing itself but also reﬂected muscle strength at baseline. Ex-
pression of the protocadherin gamma gene cluster is
negatively correlated with muscle strength in our data and
may be related to muscle denervation and re-innervation.
Clinical relevance
We have identiﬁed a gene cluster that may be related to de-
nervation and re-innervation cycles in the muscle. Loss of
motor neurons has been suggested to play an important role
in age-related muscle weakness and sarcopenia but is unfor-
tunately not yet fully understood. Prolonged resistance-type
exercise training was able to modulate the expression of
protocadherin gamma. Hence, studying the expression of this
gene may provide novel insights on whether or not denerva-
tion and re-innervation is modulated by interventions or life-
style factors such as nutrition and physical activity.
Furthermore, in this paper we show that steady-state gene
expression analysis provides information on the strength of
the muscle itself. This suggests that it could potentially be
used as a tool to provide insight into muscle strength of a
subject, but theoretically also into other muscle health-
related factors.
Limitations
While we have a large sample size for such a study, we also
have a very heterogeneous study population. The ratio of
Expression of protocadherin gamma in skeletal muscle tissue is associated with age and muscle weakness 9
Journal of Cachexia, Sarcopenia and Muscle (2016)
male to female among both groups of older adults is not en-
tirely equal. We have adjusted for this in our statistical anal-
yses where possible. Another limitation is that the muscle
biopsies from the frail older adults were obtained from a
study performed at Wageningen University, whereas the
muscle biopsies from the healthy older adults and the
young adults were obtained from studies performed at
Maastricht University. Protocols for muscle biopsy collec-
tion and preparation in Wageningen are based on those
from Maastricht and thus are very similar, but there may
still be some bias that we cannot account for statistically.
The microarray analyses were performed within the same
laboratory at the same time by the same technician,
which means that batch effects should be minimal. The
protocols for the prolonged resistance-type exercise train-
ing were slightly different for the frail older adults and the
healthy older adults. The primary difference being that the
healthy older adults trained three times per week and the
frail older adults trained twice per week. As a conse-
quence, the training stimulus for the frail older adults
was somewhat lower in these individuals, and this could
partially explain the decreased response among the frail
older subjects. This difference in treatment also prevented
us to compare the training responses in both groups
directly.
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